Perspective Therapeutics to Present at Upcoming March Investor Conferences

Core Insights - Perspective Therapeutics, Inc. is a radiopharmaceutical development company focused on advanced cancer treatment applications [3][4] - The company utilizes proprietary technology with the alpha-emitting isotope Pb to target cancer cells specifically [3][4] - Perspective is developing a "theranostic" approach that combines imaging diagnostics with treatment to enhance patient outcomes [3][4] Company Events - The company will present at the TD Cowen 45th Annual Health Care Conference on March 3, 2025, from 11:10 a.m. to 11:40 a.m. ET in Boston, MA [2] - A fireside chat is scheduled at the Barclays 27th Annual Global Healthcare Conference on March 11, 2025, from 3:30 p.m. to 3:55 p.m. ET in Miami, FL [2] - Webcast events will be available live and archived for 90 days on the company's investor page [2] Product Development - The company's melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs are currently in Phase 1/2a trials in the U.S. [4] - Perspective is expanding its network of drug product finishing facilities using its proprietary Pb generator to support clinical trials and commercial operations [4]